Cargando…

C-Peptide and Vascular Complications in Type 2 Diabetic Subjects

Detalles Bibliográficos
Autor principal:	Son, Seok Man
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486980/ https://www.ncbi.nlm.nih.gov/pubmed/23130318 http://dx.doi.org/10.4093/dmj.2012.36.5.345

Ejemplares similares

Reactive Oxygen and Nitrogen Species in Pathogenesis of Vascular Complications of Diabetes
por: Son, Seok Man
Publicado: (2012)

Chronic Vascular Complications in Diabetes
por: Jia, Weiping, et al.
Publicado: (2013)

Vascular Stem and Progenitor Cells in Diabetic Complications
por: Fadini, Gian Paolo, et al.
Publicado: (2012)

Type 2 Diabetes Mellitus and Macrovascular Complications
por: Shan, Peng-Fei, et al.
Publicado: (2017)

Unlocking the Therapeutic Potential of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination for the Pathogenesis of Atherosclerosis in Type 2 Diabetes
por: Son, Jang Won
Publicado: (2021)

Insulin Resistance, Type 1 and Type 2 Diabetes, and Related Complications 2015
por: Ndisang, Joseph Fomusi, et al.
Publicado: (2015)

Insulin Resistance, Type 1 and Type 2 Diabetes, and Related Complications 2017
por: Ndisang, Joseph Fomusi, et al.
Publicado: (2017)

Genes associated with Type 2 Diabetes and vascular complications
por: Montesanto, Alberto, et al.
Publicado: (2018)

Prediction of Diabetes Using Serum C-Peptide
por: Jung, Hye Seung
Publicado: (2016)

Receptor for advanced glycation end‐products‐mediated inflammation and diabetic vascular complications
por: Yamamoto, Yasuhiko, et al.
Publicado: (2011)

Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes
por: Fredrikson, G. N., et al.
Publicado: (2009)

Subclinical carotid vascular disease and risk factors for atherosclerosis in type 1 and type 2 diabetes
por: Rocha, Viviane Z., et al.
Publicado: (2017)

Strategies to Reduce the Cost of Renal Complications in Patients With Type 2 Diabetes
por: Gilmer, Todd P., et al.
Publicado: (2011)

Association between changes in pancreatic morphology and vascular complications in subjects with type 2 diabetes mellitus: a retrospective study
por: Iwamoto, Yuichiro, et al.
Publicado: (2022)

RAGE-Mediated Inflammation, Type 2 Diabetes, and Diabetic Vascular Complication
por: Yamamoto, Yasuhiko, et al.
Publicado: (2013)

The effect of guideline revisions on vascular complications of type 2 diabetes
por: Heijmans, Ralph, et al.
Publicado: (2019)

Lack of associations between betatrophin/ANGPTL8 level and C-peptide in type 2 diabetic subjects
por: Abu-Farha, Mohamed, et al.
Publicado: (2015)

The Influence of Different Types of Diabetes on Vascular Complications
por: Wei, Jiahua, et al.
Publicado: (2022)

Insulin Resistance, Type 1 and Type 2 Diabetes, and Related Complications: Current Status and Future Perspective
por: Ndisang, Joseph Fomusi, et al.
Publicado: (2014)

Letter: Diabetic Retinopathy and Endothelial Dysfunction in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2013;37:262-9)
por: Son, Seok Man
Publicado: (2013)

Association between Serum Cystatin C and Vascular Complications in Type 2 Diabetes Mellitus without Nephropathy
por: Kim, Hye Jeong, et al.
Publicado: (2018)

Obesity-Related Metabolic Syndrome and Vascular Complications
por: Tesauro, Manfredi, et al.
Publicado: (2013)

Correlations between Glucagon Stimulated C-peptide Levels and Microvascular Complications in Type 2 Diabetes Patients
por: Yoon, Hye-Jin, et al.
Publicado: (2012)

Role of Bilirubin in Diabetic Vascular Complications: Can Bilirubin Predict More than Just Liver Disease?
por: Moon, Jun Sung
Publicado: (2015)

Recent Updates on Vascular Complications in Patients with Type 2 Diabetes Mellitus
por: Jung, Chan-Hee, et al.
Publicado: (2020)

The Contribution of Wnt Signaling to Vascular Complications in Type 2 Diabetes Mellitus
por: Sanabria-de la Torre, Raquel, et al.
Publicado: (2022)

The CTGF gene −945 G/C polymorphism is not associated with cardiac or kidney complications in subjects with type 2 diabetes
por: Patel, Sheila K, et al.
Publicado: (2012)

Glycated albumin and the risk of micro- and macrovascular complications in subjects with Type 1 Diabetes
por: Yoon, Hye-jin, et al.
Publicado: (2015)

Role of Hyperbaric Oxygen Therapy on Microvascular Diabetic Complications and Metabolic Profile among Patients with Type 2 Diabetes Mellitus
por: Al-Rawahi, Abdulhakeem
Publicado: (2020)

Cognition in type 2 diabetes: Association with vascular risk factors, complications of diabetes and depression
por: Iype, Thomas, et al.
Publicado: (2009)

C-peptide and Central Nervous System Complications in Diabetes
por: Li, Zhen-guo, et al.
Publicado: (2004)

Complications of Diabetes
por: Papatheodorou, Konstantinos, et al.
Publicado: (2015)

C-Peptide-Based Index Is More Related to Incident Type 2 Diabetes in Non-Diabetic Subjects than Insulin-Based Index
por: Kim, Jong-Dai, et al.
Publicado: (2016)

Functional Vascular Study in Hypertensive Subjects with Type 2 Diabetes Using Losartan or Amlodipine
por: Pozzobon, Cesar Romaro, et al.
Publicado: (2014)

Association between interleukin‐19 and angiopoietin‐2 with vascular complications in type 2 diabetes
por: Li, Li, et al.
Publicado: (2016)

Molecular Mechanisms of Pregnancy-Related Vascular Remodeling and Pregnancy Complications
por: Stevenson, David K., et al.
Publicado: (2023)

Complications of Diabetes 2016
por: Papatheodorou, Konstantinos, et al.
Publicado: (2016)

Complications of Diabetes 2017
por: Papatheodorou, Konstantinos, et al.
Publicado: (2018)

Diabetic Microvascular Complications
por: Migdalis, I., et al.
Publicado: (2018)

Cardiac Complications of Diabetes
por: Abi Khalil, Charbel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lrlal4c7ljurmuhpuahb2c9jn4